Zhiqiang AN

Person

Houston, TX, US

People

Patents Grantslast 30 patents

Information Patent Grant
EGFL6 specific monoclonal antibodies and methods of their use
- Patent number 12,152,071
- Issue date Nov 26, 2024
- The Board of Regents of the University of Texas System
- Ningyan Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Linkers for antibody drug conjugates
- Patent number 12,084,403
- Issue date Sep 10, 2024
- The Board of Regents of the University of Texas System
- Kyoji Tsuchikama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Leptin antibodies and method of reducing leptin
- Patent number 12,037,390
- Issue date Jul 16, 2024
- Board of Regents, The University of Texas System
- Zhiqiang An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating metastasis, including inhibiting bone cancer me...
- Patent number 11,912,758
- Issue date Feb 27, 2024
- The Board of Regents of the University of Texas System
- Jean X. Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for identifying LILRB-blocking antibodies
- Patent number 11,906,519
- Issue date Feb 20, 2024
- The Board of Regents of the University of Texas System
- Chengcheng Zhang
- G01 - MEASURING TESTING
Information Patent Grant
Leptin antibodies
- Patent number 11,760,799
- Issue date Sep 19, 2023
- Board of Regents, The University of Texas System
- Zhiqiang An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Linkers for antibody drug conjugates
- Patent number 11,629,122
- Issue date Apr 18, 2023
- The Board of Regents of the University of Texas System
- Kyoji Tsuchikama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-LILRB antibodies and their use in detecting and treating cancer
- Patent number 11,498,963
- Issue date Nov 15, 2022
- The Board of Regents of the University of Texas System
- Chengcheng Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) mo...
- Patent number 11,377,491
- Issue date Jul 5, 2022
- The Board of Regents of the University of Texas System
- X. Charlene Liao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CMV neutralizing antigen binding proteins
- Patent number 11,230,591
- Issue date Jan 25, 2022
- Merck Sharp & Dohme Corp.
- Tong-Ming Fu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
- Patent number 11,174,320
- Issue date Nov 16, 2021
- The Board of Regents of the University of Texas System
- Ningyan Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Endotrophin neutralization and use thereof
- Patent number 10,975,142
- Issue date Apr 13, 2021
- The Board of Regents of the University of Texas System
- Philipp Erich Scherer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating an osteolytic tumor and spinal cord injury by a...
- Patent number 10,889,637
- Issue date Jan 12, 2021
- The Board of Regents of the University of Texas System
- Jean X. Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGFL6 specific monoclonal antibodies and methods of their use
- Patent number 10,875,912
- Issue date Dec 29, 2020
- The Board of Regents of the University of Texas System
- Ningyan Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-LILRB antibodies and their use in detecting and treating cancer
- Patent number 10,501,538
- Issue date Dec 10, 2019
- The Board of Regents of the University of Texas System
- Chengcheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
- Patent number 10,358,501
- Issue date Jul 23, 2019
- The Board of Regents of the University of Texas System
- Ningyan Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Endotrophin neutralization and use thereof
- Patent number 10,221,235
- Issue date Mar 5, 2019
- The Board of Regents of the University of Texas System
- Philipp Erich Scherer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 10,106,617
- Issue date Oct 23, 2018
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CMV neutralizing antigen binding proteins
- Patent number 9,868,777
- Issue date Jan 16, 2018
- Merck Sharp & Dohme Corp.
- Tong-Ming Fu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 9,777,062
- Issue date Oct 3, 2017
- CSL Limited
- Andrew Donald Nash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
- Patent number 9,725,520
- Issue date Aug 8, 2017
- The Board of Regents of the University of Texas System
- Ningyan Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Endotrophin neutralization and use thereof
- Patent number 9,605,057
- Issue date Mar 28, 2017
- Board of Regents of the University of Texas System
- Philipp Erich Scherer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 9,371,388
- Issue date Jun 21, 2016
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 8,889,138
- Issue date Nov 18, 2014
- Merck Sharp & Dohme Corp.
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IL-13Rα1 antibodies and their uses thereof
- Patent number 8,613,925
- Issue date Dec 24, 2013
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 8,568,722
- Issue date Oct 29, 2013
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL monoclonal antibody and use thereof
- Patent number 8,420,093
- Issue date Apr 16, 2013
- Merck Sharp & Dohme Corp.
- Gene Kinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 8,383,113
- Issue date Feb 26, 2013
- Northwestern University
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody antagonists of interleukin-13 receptor α1
- Patent number 8,207,304
- Issue date Jun 26, 2012
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 8,128,930
- Issue date Mar 6, 2012
- Northwestern University
- Paul Acton
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
LILRB2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE
- Publication number 20240392001
- Publication date Nov 28, 2024
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TFR ANTIGEN BINDING PROTEINS AND USES THEREOF
- Publication number 20240376222
- Publication date Nov 14, 2024
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREM2 ANTIGEN BINDING PROTEINS AND USES THEREOF
- Publication number 20240376199
- Publication date Nov 14, 2024
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TO CHITINASE 3-LIKE-1 AND METHODS OF USE THEREFOR
- Publication number 20240294670
- Publication date Sep 5, 2024
- The Board of Regents of the University of Texas System
- Cynthia JU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONNEXIN (Cx)43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF
- Publication number 20240254212
- Publication date Aug 1, 2024
- Board of Regents, The University of Texas System
- JEAN X. JIANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES
- Publication number 20240101667
- Publication date Mar 28, 2024
- The Board of Regents of the University of Texas System
- Chengcheng ZHANG
- G01 - MEASURING TESTING
Information Patent Application
LINKERS FOR ANTIBODY DRUG CONJUGATES
- Publication number 20240059647
- Publication date Feb 22, 2024
- The Board of Regents of the University of Texas System
- Kyoji TSUCHIKAMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CORONAVIRUS SPIKE PROTEIN AND METHODS OF USE THEREOF
- Publication number 20230399384
- Publication date Dec 14, 2023
- The Board of Regents of the University of Texas System
- Zhiqiang KU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Leptin Antibodies
- Publication number 20230374126
- Publication date Nov 23, 2023
- Board of Regents, The University of Texas System
- Zhiqiang An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS AND USES THEREOF
- Publication number 20230348586
- Publication date Nov 2, 2023
- The Board of Regents of the University of Texas System
- Phillipp E. SCHERER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST LILRB1 FOR DIAGNOSTIC AND THERAPEUTIC...
- Publication number 20230235055
- Publication date Jul 27, 2023
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL DDR1 ANTIBODIES AND USES THEREOF
- Publication number 20230235078
- Publication date Jul 27, 2023
- The Board of Regents of the University of Texas System
- Ningyan ZHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL DDR1 ANTIBODIES AND USES THEREOF
- Publication number 20230130372
- Publication date Apr 27, 2023
- The Board of Regents of the University of Texas System
- Ningyan ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL LILRB2 ANTIBODIES AND USES THEREOF
- Publication number 20230068663
- Publication date Mar 2, 2023
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF
- Publication number 20220267415
- Publication date Aug 25, 2022
- The Board of Regents of the University of Texas System
- Zhiqiang KU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF
- Publication number 20220056124
- Publication date Feb 24, 2022
- The Board of Regents of the University of Texas System
- Ningyan ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL LILRB4 ANTIBODIES AND USES THEREOF
- Publication number 20210371518
- Publication date Dec 2, 2021
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NMES1 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20210371508
- Publication date Dec 2, 2021
- The Board of Regents of the University of Texas System
- Ningyan ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES
- Publication number 20210349096
- Publication date Nov 11, 2021
- Chengcheng ZHANG
- G01 - MEASURING TESTING
Information Patent Application
CONNEXIN (CX) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF
- Publication number 20210253680
- Publication date Aug 19, 2021
- The Board of Regents of the University of Texas System
- Jean X. Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Leptin Antibodies
- Publication number 20210188970
- Publication date Jun 24, 2021
- Board of Regents, The University of Texas System
- Zhiqiang An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING LILRB4 WITH CAR-T OR CAR-NK CELLS IN THE TREATMENT OF CANCER
- Publication number 20210179687
- Publication date Jun 17, 2021
- The Board of Regents of the University of Texas System
- Chengcheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE
- Publication number 20210130450
- Publication date May 6, 2021
- The Board of Regents of the University of Texas System
- Ningyan ZHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LINKERS FOR ANTIBODY DRUG CONJUGATES
- Publication number 20200115326
- Publication date Apr 16, 2020
- The Board of Regents of the University of Texas System
- Kyoji TSUCHIKAMA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-LILRB ANTIBODIES AND THEIR USE IN DETECTING AND TREATING CANCER
- Publication number 20200079851
- Publication date Mar 12, 2020
- The Board of Regents of the University of Texas System
- Chengcheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HER3 SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
- Publication number 20200055954
- Publication date Feb 20, 2020
- The Board of Regents of the University of Texas System
- Ningyan ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENDOTROPHIN NEUTRALIZATION AND USE THEREOF
- Publication number 20200024333
- Publication date Jan 23, 2020
- The Board of Regents of the University of Texas System
- Philipp Erich SCHERER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONNEXIN (CX) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF
- Publication number 20190359696
- Publication date Nov 28, 2019
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TAXAS SYSTEM
- Jean X. Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-LAIR1 ANTIBODIES AND THEIR USES
- Publication number 20190338026
- Publication date Nov 7, 2019
- The Board of Regents of the University of Texas System
- X. Charlene LIAO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CMV NEUTRALIZING ANTIGEN BINDING PROTEINS
- Publication number 20190106481
- Publication date Apr 11, 2019
- MERCK SHARP & DOHME CORP.
- Tong-Ming Fu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Zhiqiang AN

Person

Patents Grantslast 30 patents

EGFL6 specific monoclonal antibodies and methods of their use

Linkers for antibody drug conjugates

Leptin antibodies and method of reducing leptin

Methods of treating metastasis, including inhibiting bone cancer me...

Methods for identifying LILRB-blocking antibodies

Leptin antibodies

Linkers for antibody drug conjugates

Anti-LILRB antibodies and their use in detecting and treating cancer

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) mo...

CMV neutralizing antigen binding proteins

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Endotrophin neutralization and use thereof

Methods of treating an osteolytic tumor and spinal cord injury by a...

EGFL6 specific monoclonal antibodies and methods of their use

Anti-LILRB antibodies and their use in detecting and treating cancer

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Endotrophin neutralization and use thereof

High affinity antibody antagonists of interleukin-13 receptor alpha 1

CMV neutralizing antigen binding proteins

High affinity antibody antagonists of interleukin-13 receptor alpha 1

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Endotrophin neutralization and use thereof

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Anti-ADDL antibodies and uses thereof

Anti-IL-13Rα1 antibodies and their uses thereof

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Anti-ADDL monoclonal antibody and use thereof

Anti-ADDL antibodies and uses thereof

Antibody antagonists of interleukin-13 receptor α1

Anti-ADDL antibodies and uses thereof

Patents Applicationslast 30 patents

LILRB2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

TFR ANTIGEN BINDING PROTEINS AND USES THEREOF

TREM2 ANTIGEN BINDING PROTEINS AND USES THEREOF

ANTIBODIES TO CHITINASE 3-LIKE-1 AND METHODS OF USE THEREFOR

CONNEXIN (Cx)43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF

METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES

LINKERS FOR ANTIBODY DRUG CONJUGATES

ANTIBODIES TO CORONAVIRUS SPIKE PROTEIN AND METHODS OF USE THEREOF

Leptin Antibodies

THERAPEUTIC AGENTS AND USES THEREOF

MONOCLONAL ANTIBODIES AGAINST LILRB1 FOR DIAGNOSTIC AND THERAPEUTIC...

NOVEL DDR1 ANTIBODIES AND USES THEREOF

NOVEL DDR1 ANTIBODIES AND USES THEREOF

NOVEL LILRB2 ANTIBODIES AND USES THEREOF

MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF

MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF

NOVEL LILRB4 ANTIBODIES AND USES THEREOF

NMES1 ANTIBODIES AND METHODS OF USE THEREOF

METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES

CONNEXIN (CX) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF

Leptin Antibodies

TARGETING LILRB4 WITH CAR-T OR CAR-NK CELLS IN THE TREATMENT OF CANCER

EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

LINKERS FOR ANTIBODY DRUG CONJUGATES

ANTI-LILRB ANTIBODIES AND THEIR USE IN DETECTING AND TREATING CANCER

HER3 SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE

ENDOTROPHIN NEUTRALIZATION AND USE THEREOF

CONNEXIN (CX) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF

ANTI-LAIR1 ANTIBODIES AND THEIR USES

CMV NEUTRALIZING ANTIGEN BINDING PROTEINS